KBC Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$310M Sell
1,269,307
-1,027,524
-45% -$239M 0.78% 15
2025
Q4
$475M Buy
2,296,831
+410,720
+22% +$81.2M 1.08% 12
2025
Q3
$350M Buy
1,886,111
+911,559
+94% +$156M 0.84% 17
2025
Q2
$149M Buy
974,552
+578,502
+146% +$88.9M 0.4% 47
2025
Q1
$65.7M Sell
396,050
-511,852
-56% -$80.1M 0.2% 123
2024
Q4
$131M Sell
907,902
-16,842
-2% -$2.61M 0.36% 48
2024
Q3
$150M Sell
924,744
-356,939
-28% -$56.9M 0.45% 38
2024
Q2
$187M Buy
1,281,683
+356,516
+39% +$53M 0.57% 26
2024
Q1
$146M Sell
925,167
-870,086
-48% -$138M 0.46% 44
2023
Q4
$281M Sell
1,795,253
-190,926
-10% -$29.3M 1% 14
2023
Q3
$309M Buy
1,986,179
+27,672
+1% +$4.57M 1.26% 8
2023
Q2
$324M Buy
1,958,507
+464,207
+31% +$74.9M 1.33% 9
2023
Q1
$232M Sell
1,494,300
-165,151
-10% -$26.7M 0.98% 13
2022
Q4
$293M Buy
1,659,451
+485,948
+41% +$83.9M 1.42% 8
2022
Q3
$192M Sell
1,173,503
-21,453
-2% -$3.63M 1% 14
2022
Q2
$212M Sell
1,194,956
-89,185
-7% -$15.9M 1.06% 13
2022
Q1
$228M Sell
1,284,141
-241,425
-16% -$41.1M 0.9% 13
2021
Q4
$261M Buy
1,525,566
+204,679
+15% +$33.5M 0.86% 17
2021
Q3
$213M Sell
1,320,887
-768,129
-37% -$131M 0.78% 21
2021
Q2
$344M Buy
2,089,016
+55,530
+3% +$9.19M 0.62% 29
2021
Q1
$334M Sell
2,033,486
-151,630
-7% -$24.5M 0.68% 25
2020
Q4
$1.89B Buy
2,185,116
+535,512
+32% +$79M 0.81% 18
2020
Q3
$246M Sell
1,649,604
-311,310
-16% -$46.1M 0.72% 22
2020
Q2
$276M Buy
1,960,914
+1,273,270
+185% +$186M 0.92% 21
2020
Q1
$90.2M Sell
687,644
-157,067
-19% -$22.3M 0.75% 25
2019
Q4
$123M Sell
844,711
-142,698
-14% -$19.4M 0.78% 21
2019
Q3
$128M Buy
987,409
+57,872
+6% +$7.62M 0.94% 16
2019
Q2
$129M Buy
929,537
+60,925
+7% +$8.43M 1% 11
2019
Q1
$121M Buy
868,612
+11,177
+1% +$1.5M 1% 13
2018
Q4
$111M Buy
857,435
+75,536
+10% +$10.5M 1.23% 9
2018
Q3
$108M Buy
781,899
+1,408
+0.2% +$187K 0.82% 14
2018
Q2
$94.7M Sell
780,491
-200,683
-20% -$25M 0.82% 13
2018
Q1
$126M Sell
981,174
-70,115
-7% -$9.48M 1.16% 8
2017
Q4
$147M Sell
1,051,289
-233,935
-18% -$32.6M 1.26% 5
2017
Q3
$167M Sell
1,285,224
-90,039
-7% -$11.9M 1.52% 5
2017
Q2
$182M Sell
1,375,263
-320,850
-19% -$40.9M 1.76% 3
2017
Q1
$211M Sell
1,696,113
-34,098
-2% -$4.07M 1.91% 2
2016
Q4
$199M Buy
1,730,211
+213,984
+14% +$24.7M 1.98% 2
2016
Q3
$179M Buy
1,516,227
+477,488
+46% +$57.9M 2.12% 1
2016
Q2
$126M Buy
1,038,739
+324,373
+45% +$36.9M 1.8% 3
2016
Q1
$77.3M Buy
714,366
+105,410
+17% +$10.9M 1.28% 5
2015
Q4
$62.6M Buy
608,956
+114,649
+23% +$11.5M 1.15% 8
2015
Q3
$46.1M Sell
494,307
-126,928
-20% -$12.3M 0.93% 12
2015
Q2
$60.5M Buy
621,235
+40,288
+7% +$4.03M 0.78% 13
2015
Q1
$58.4M Sell
580,947
-275,946
-32% -$28.1M 0.75% 15
2014
Q4
$89.6M Buy
856,893
+764,105
+823% +$80.5M 1.07% 9
2014
Q3
$9.89M Sell
92,788
-828,166
-90% -$85.9M 0.35% 61
2014
Q2
$96.4M Buy
920,954
+178,319
+24% +$18M 1.1% 8
2014
Q1
$72.9M Sell
742,635
-236,200
-24% -$21.9M 1.15% 10
2013
Q4
$89.7M Buy
978,835
+41,270
+4% +$3.8M 1.36% 7
2013
Q3
$81.3M Buy
937,565
+133,770
+17% +$12M 1.31% 7
2013
Q2
$69M Buy
+803,795
New +$68.2M 1.28% 6

Other funds holding JNJ

KBC Group's JNJ Position: Q1 2026 in Review

KBC Group reduced its Johnson & Johnson (JNJ) stake by 45% in Q1 2026, selling an estimated $239M and leaving 1,269,307 shares worth $310M. The position accounts for 0.78% of the portfolio, ranked #15.

KBC Group first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.89B in Q4 2020. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • KBC Group held 1,269,307 shares of Johnson & Johnson worth $310M as of Q1 2026.
  • KBC Group sold 1,027,524 Johnson & Johnson shares in Q1 2026, an estimated $239M.
  • Johnson & Johnson made up 0.78% of KBC Group's portfolio in Q1 2026, its #15 holding.
  • KBC Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • KBC Group's Johnson & Johnson position peaked at $1.89B in Q4 2020.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.